FinTech expert Dr. Tobias Riethmüller returns to GSK
Munich — GSK Stockmann can report an important step in the expansion of its FinTech and LegalTech advisory practice. On January 1, 2019, Dr. Tobias Riethmüller (39, photo), one of the experts on digital financing models from the very beginning, returned to GSK Stockmann as Equity Partner. He worked in GSK’s Frankfurt office until August 2015, after which he joined Schiedermair Rechtsanwälte.
Tobias Riethmüller is qualified as a lawyer and graduate economist. He advises clients in all phases of corporate development on corporate and capital market law issues as well as on corporate and project financing. Tobias Riethmüller has particular experience and expertise in the legal structuring of digital financing platforms and standardized issuance models. Since 2008, he has advised over 40 national and international digital financing platforms on structuring equity, debt and securities-based models. In 2015 and 2018, he served as a federal expert witness on regulatory proposals in this area. His work for financing platforms also includes the design of IT processes in compliance with supervisory law and the automation of database-supported contract processing.
“We are very pleased about the return of Tobias Riethmüller to GSK Stockmann. With his expertise in FinTech and LegalTech, we will be able to significantly broaden our regulatory and capital markets expertise in the area of bank-independent financing models,” comments Max Wilmanns, spokesperson of the Corporate practice group at GSK Stockmann. “There is also enormous cross-selling potential with colleagues from the banking/finance area, the IT/data protection colleagues and the Luxembourg office. Finally, Tobias Riethmüller can also support us in our own LegalTech projects.”
Tobias Riethmüller’s advisory focus is on the future industries of interest to GSK Stockmann, namely FinTech, in particular digital investment brokerage, LegalTech/Legal Engineering and PropTech. Due to his intensive networking in the industry as legal counsel of the Bundesverband Crowdfunding (BVCF) e.V. and founding member of the German Crowdfunding Network (GCN), Tobias Riethmüller is always involved in regulatory changes and current market developments. “I am happy to be back at GSK Stockmann and to be able to directly benefit from the expertise on regulatory issues available at GSK Stockmann,” commented Tobias Riethmüller. “Over the past three years, I have kept in touch with GSK Stockmann and have always worked with former colleagues in regulatory law, including Luxembourg.”
Through his network, Tobias Riethmüller has direct access to innovative consulting fields such as crypto asset platforms and token issuances. “We will now be able to implement these new areas of advice, which are characterized by ever-increasing complexity, internationality and digitalization, especially in the area of regulatory and capital markets law, even better than before,” says Dr. Timo Patrick Bernau, Banking Partner and FinTech specialist at GSK Stockmann.
For GSK Stockmann, Tobias Riethmüller’s addition offers diverse growth potential. This applies in particular to the expansion of the network to include new clients who want to benefit from the innovative expertise of FinTechs, as well as the increased inclusion of securitization models and structured finance in cooperation with the Luxembourg office of GSK Stockmann. The Corporate division will particularly benefit from Tobias Riethmüller’s expertise in the issuance of capital market instruments in the equity, debt and mezzanine areas and the legal and economic structuring of standardized issuance models — also in the venture capital area.
Dr. Tobias Riethmüller brings with him as associate Kathrin Müller, a lawyer specializing in regulatory and capital markets law. With the two additions, the Corporate practice grows to a total of 20 Equity Partners, 8 Local Partners and 32 Associates.